Ginkgo Investor Conference Presentation Deck
Ginkgo more than doubled the number of products in
scale production by our customers in 2021
Product
Ginkgo organism?
Ginkgo process?
Approx Year Started
Year Completed
Customer
Primary End Market
Organism
Product Type
Mfg Scale (L)
Downstream
Economics
Peach
ā
2014
2019
ROBERTET
Consumer
Fungal
(Species 1)
Small Molecule
Coconut
Royalty/Toll
ā
2016
2019
ROBERTET
Consumer
Fungal
(Species 2)
Small Molecule
[Confidential]
Royalty/Toll
2016
2018
(mfg began in 2020)
[Confidential]
Chemicals
Bacterial
(Species 3)
Small Molecule
VCE
Royalty/Toll
2020
2021
aldevron
Pharma
Bacterial
(Species 4)
Protein
Myoglobin
Royalty
2018
2021
motif
FOOD/CFHS
Food
Fungal
(Species 5)
Protein
Equity
CBG
Note: "Ginkgo organism" refers to a strain engineered by Ginkgo, whereas "Ginkgo process" refers to a manufacturing process developed by Ginkgo
2018
2021
CRONOS
GROUP
Consumer
Fungal
(Species 6)
Small Molecule
[Confidential]
Most being produced in tanks at the 25,000 - 50,000L scale; some pharma products produced at lower scale (hundreds to 1,000L)
Milestone
2020
2021
[Confidential]
Pharma
Bacterial
(Species 4)
Nucleic Acid
Milestone
CBGV
2018
2021
CRONOS
GROUP
Consumer
Fungal
(Species 6)
Small Molecule
Pilot Scale
Milestone
10
Property of Ginkgo Bioworks
J.P. MORGAN HEALTHCARE CONFERENCE 2022View entire presentation